Vir Biotechnology, Inc. (NASDAQ:VIR) Q2 2025 Earnings Call Transcript August 6, 2025
Vir Biotechnology, Inc. misses on earnings expectations. Reported EPS is $-0.8 EPS, expectations were $-0.72.
Operator: Hello. Welcome to Vir Biotechnology’s Second Quarter 2025 Financial Results and Corporate Update Call. As a reminder, this conference call is being recorded. [Operator Instructions] I will now turn the call over to Rich Lepke, Senior Director, Investor Relations. You may begin Mr....
